Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients

Journal of Hypertension

Volumn 19, Issue 8, 2001, Pages 1379-1386

  Taddei, Stefano ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Magagna, Armando ^a   Pasini, Anna Fratta ^b   Garbin, Ulisse ^b   Cominacini, Luciano ^b   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Acetylcholine; Bradykinin; Endothelium; Free radicals; Hypertension; Nitric oxide

Indexed keywords

ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM ANTAGONIST; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VASODILATATION;

EID: 0034897608     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200108000-00005     Document Type: Article

References (37)

1. Superoxide anion is an endothelium-derived contracting factor
2. Endothelial dysfunction in hypertension. Fact or fancy?
3. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
4. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired NO availability in essential hypertensive patients
5. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
6. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary artery disease
7. Structure and function of resistance arteries of hypertensive patients treated with β-blocker or a calcium channel antagonist
8. Normalisation of abnormal coronary vasomotion by calcium antagonists in patients with hypertension
9. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients
10. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with a-tocopherol
11. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells
12. Lacidipine: A dihydropyridine calcium antagonist with antioxidant activity
13. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension
14. The measurement of volume changes in human limbs
15. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
16. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients
17. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification
18. 2 in cultured endothelial cells
19. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: Inhibitory effect of lacidipine
20. Culture of human endothelial cells derived from umbilical veins
21. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens
22. G-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal
23. G-monomethyl-arginine in patients with essential hypertension
24. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension
25. Intracellular calcium, currents and stimulus-response coupling in endothelial cells
26. Role of calcium in the activation of endothelial cells
27. Low-density lipoprotein oxidation in essential hypertension
28. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension
29. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension
30. Vitamin E and other lipophilic antioxidants protect LDL against oxidation
31. Antioxidants in relation to lipid peroxidation
32. Non-enzymatic oxidation of lipids lipoproteins: The role of metals and nitric oxide
33. Nifedipine improves nitric oxide-mediated vasodilation in hypercholesterolemia, independent of an effect on blood pressure or plasma lipids
34. Treatment of hypertension with ascorbic acid
35. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
36. The ELSA trial: Protocol of a randomised trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension